title: Sairei-to therapy on alloimmune recurrent spontaneous abortions and alloimmune-, autoimmune complicated recurrent spontaneous abortions.
abstract: Alloimmune recurrent spontaneous abortion (RSA) cases that could not be treated with lymphocyte transfusion due to medical and social reasons were treated with Sairei-to therapy as an emergency measure and all four cases resulted in live births. This may show that Sairei-to treatment is effective in preventing alloimmune RSA. The efficacy of Sojyutsu-Sairei-to and Byakujyutsu-Sairei-to on autoimmune RSA has already been proven. When they were used in the treatment of alloimmune-, autoimmune complicated RSA, the abortion prevention rates were 65.4% and 82.3% respectively. These results indicate that Sairei-to is effective in the treatment of alloimmune RSA and alloimmune-, autoimmune complicated RSA.
authors.affiliation: Medical Corporation Kano Clinic, Chuo-ku, Osaka, Japan. kanoclin@pearl.ocn.ne.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Kano
authors.forename: Masahiko
authors.initials: M
authors.lastname: Shimizu
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Kanda
authors.forename: Yasuyo
authors.initials: Y
authors.lastname: Hijikata
mesh_terms: D000026:Abortion, Habitual / Q000276:immunology / Q000517:prevention & control*; D000328:Adult; D001327:Autoimmune Diseases / Q000150:complications; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D054502:Histocompatibility, Maternal-Fetal / Q000187:drug effects*; D006801:Humans; D007154:Immune System Diseases / Q000150:complications*; D050498:Live Birth; D019684:Magnoliopsida; D008517:Phytotherapy; D011247:Pregnancy
chemical_list: D004365:Drugs, Chinese Herbal; C080903:sairei-to